Quantification of the relationship between desmopressin concentration and Von Willebrand factor in Von Willebrand disease type 1: A pharmacodynamic study-Reference-Cited by-同舟云学术

Quantification of the relationship between desmopressin concentration and Von Willebrand factor in Von Willebrand disease type 1: A pharmacodynamic study

Published:2022-05-08 Issue:5 Volume:28 Page:814-821
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:Haemophilia

Author:

Heijdra Jessica M.¹^ORCID,Cloesmeijer Michael E.²^ORCID,de Jager Nico C.B.²,Leebeek Frank W.G.³^ORCID,Kruip Marieke H.J.A.³^ORCID,Cnossen Marjon H.¹,Mathôt Ron A.A.²,

Affiliation:

1. Department of Paediatric Haematology Erasmus MC Sophia Children's Hospital University Medical Centre Rotterdam The Netherlands

2. Department of Hospital Pharmacy – Clinical Pharmacology Amsterdam UMC University of Amsterdam Amsterdam The Netherlands

3. Department of Haematology Erasmus MC Erasmus University Medical Centre Rotterdam The Netherlands

Publisher

Wiley

Subject

Genetics (clinical),Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hae.14582

Reference20 articles.

1. Von Willebrand’s Disease

2. Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor

3. ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease

4. Desmopressin – a haemostatic drug: state‐of‐the‐art review;Lethagen S;Eur J Anaesthesiol | EJA,1997

5. Mechanism of Plasminogen Activator and Factor VIII Increase after Vasoactive Drugs

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Desmopressin to prevent and treat bleeding in pregnant women with an inherited bleeding disorder: a systematic literature review;Journal of Thrombosis and Haemostasis;2024-01